Quantcast Section III. Analeptic Agents (Brain Stem Stimulants) - Pharmacology I

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
(3)  Methamphetamine hydrochloride (Desoxyn). This drug is similar to
dextroamphetamine in terms of its ability to suppress the appetite. However, its abuse
potential is such that it is rarely used any longer for this purpose.
c.  Other Agents. Many other drugs produce pharmacological effects similar
to those produced by the amphetamines. These are most often used for their ability to
suppress the patient's appetite. Sometimes you will find these medications combined
with other drugs (for example, a sedative or an antianxiety agent) in order to counteract
the stimulation they produce.
(1)  Pemoline (Cylert). This drug is used in the treatment of ADHD. It is
usually prescribed in a graduated dose - beginning with a 37.5-milligram daily dose. It
is then gradually increased at 1-week intervals of 18.75 milligrams until a desired clinical
response is observed. The most common side effect seen with this agent is insomnia.
Pemoline appears to have a lower abuse potential than methylphenidate; pemoline is
classified as a Note Q drug. The drug is supplied in the form of 18.75, 37.5, and 75
milligram tablets.
(2)  Diethylpropion hydrochloride (Tenuate). Diethylpropion hydrochloride
is used as an appetite suppressant. It is less effective in this use than the
amphetamines. It produces such side effects as dryness of the mouth, nausea, and
headaches. It is available in both 25-milligram tablets and 75-milligram (timed-release)
tablets. Diethylpropion is a Note Q drug.
(3)  Phendimetrazine tartrate (Prelu-2). This drug is used as an appetite
suppressant. Long-term use of the drug, especially in large doses, may produce
psychic dependence. It produces such side effects as nervousness, excitement,
euphoria, and dryness of the mouth. It is supplied in 35-mIlligram tablets and capsules
and 105-milligram (timed-release) capsules. Phendimetrazine is a Note Q drug.
Section III. ANALEPTIC AGENTS (BRAIN STEM STIMULANTS)
10-6. INTRODUCTION
a.  Analeptic agents are drugs that produce two primary effects. One, they
stimulate the nerve cells of the body's respiratory center when it has been depressed by
some condition (for example, illness or drugs). Two, they stimulate nerve cell centers
responsible for keeping a person conscious.
b.  Analeptic agents are not commonly used today because of the stimulation
they produce in doses sufficient to produce their analeptic effect. These agents can
produce such undesirable effects as convulsions, respiratory problems, or vomiting.
MD0804
10-5



Medical News
ESC: Gout Drug Gets Thumbs Down in Heart Surgery
BARCELONA (MedPage Today) -- Findings from two trials suggested the...
medpagetoday.com
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include treating adolescent depression,...
medpagetoday.com
Grand Roundup: Top posts for the week of Aug. 24
The five most-read stories this week on Scope were: “Sleep...
scopeblog.stanford.edu
Grand Roundup: Top posts for the week of Aug. 24
The five most-read stories this week on Scope were: “Sleep...
scopeblog.stanford.edu
To Pee or Not to Pee? That's Improbable!
(MedPage Today) -- That?s Improbable! is MedPage Today?s weekly roundup...
medpagetoday.com
ESC on SIGNIFY: No Comment
BARCELONA (MedPage Today) -- The results of SIGNIFY, a study...
medpagetoday.com
Firm Date for ICD-10 Switch Still Not Raising Urgency
WASHINGTON (MedPage Today) -- Although there is a firm date...
medpagetoday.com
ESC: Gout Drug Some Help in Heart Surgery (CME/CE)
BARCELONA (MedPage Today) -- Giving the gout drug colchicine perioperatively...
medpagetoday.com
ESC: Novel Heart Failure Drug a Game-Changer (CME/CE)
(MedPage Today) -- An investigational heart failure drug being developed...
medpagetoday.com
Tax forms could pose challenge for HealthCare.gov
If you got health coverage through President Barack Obama's law...
medicalxpress.com
Sudden death predictor identifies ICD candidates in new ESC Guidelines
Saturday 30 August 2014: A new sudden death predictor for...
medicalxpress.com
The early cost of HIV: Inflammatory response breaks down intestinal lining, but help may come from friendly bacteria
Researchers at UC Davis have made some surprising discoveries about...
medicalxpress.com
First expert consensus on ventricular arrhythmias published
The first expert consensus on ventricular arrhythmias is published today....
medicalxpress.com
First comprehensive ESC Guidelines on aortic diseases published
The first comprehensive ESC Guidelines on aortic diseases are published...
medicalxpress.com
First recommendations on all new oral anticoagulants in pulmonary embolism published
The first recommendations on the use of all new oral...
medicalxpress.com
First multidisciplinary recommendations on management of arrhythmias in ACS patients
The first multidisciplinary recommendations on the management of arrhythmias in...
medicalxpress.com
ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD
The therapeutic benefit of revascularisation in coronary artery disease (CAD)...
medicalxpress.com
Study shows cavities have become the most common childhood disease
A Washington Post blog entry published earlier this week reports...
scopeblog.stanford.edu
Study shows cavities have become the most common childhood disease
A Washington Post blog entry published earlier this week reports...
scopeblog.stanford.edu
CMS Shuts Down Sunshine Act Database -- Again
WASHINGTON (MedPage Today) -- The Centers for Medicare and Medicaid...
medpagetoday.com
 


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +